NCT00517881 Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia Status TERMINATED Phase PHASE3
NCT00517816 A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma. Status COMPLETED Phase PHASE1
NCT00517699 A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. Status TERMINATED Phase PHASE2
NCT00517530 A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN) Status COMPLETED Phase PHASE1/PHASE2
NCT00517465 A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE1
NCT00517439 A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection. Status COMPLETED Phase PHASE2
NCT00517413 LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Status COMPLETED Phase PHASE3
NCT00504777 A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents. Status COMPLETED Phase PHASE4
NCT00504270 A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. Status COMPLETED Phase PHASE2
NCT00503425 A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. Status COMPLETED Phase PHASE3
NCT00503113 A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. Status COMPLETED Phase PHASE4
NCT00502996 A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE3
NCT00502853 A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE4
NCT00502840 A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. Status COMPLETED Phase PHASE3
NCT00502736 A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. Status COMPLETED Phase PHASE2
NCT00502710 A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes. Status COMPLETED Phase PHASE2
NCT00502671 A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. Status COMPLETED Phase PHASE4
NCT00502632 Dornase Alfa and Urokinase for Kids With Pleural Empyema Status UNKNOWN Phase PHASE2/PHASE3
NCT00496457 Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy Status COMPLETED Phase PHASE2
NCT00493623 BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis. Status COMPLETED Phase PHASE3